← Holders
Krensavage Asset Management, LLC
What Krensavage Asset Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1609251 · Filed Nov 17, 2026
- Positions
- 20
- Reported value
- $265.4K
- Opened
- 3
- Closed
- 1
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$234.7K17 positions
- Dec 31, 2025$283.1K18 positions
- Mar 31, 2026$255.7K20 positions
- Jun 30, 2026$263.2K18 positions
- Sep 30, 2026$265.4K20 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
JAZZJazz Pharmaceuticals plc | 167.8K | ±0% | $38.9K | 14.6% |
ENTAEnanta Pharmaceuticals Inc | 2.9M | ±0% | $37.8K | 14.2% |
UTHRUnited Therapeutics Corp | 66.3K | −4.3% | $35.9K | 13.5% |
BMRNBioMarin Pharmaceutical Inc | 524.8K | ±0% | $31.5K | 11.9% |
ABTAbbott Laboratories | 200K | ±0% | $19.8K | 7.4% |
EXELExelixis, Inc. | 299.4K | −19.2% | $17.5K | 6.6% |
RAREUltragenyx Pharmaceutical Inc. | 1.1M | +191.9% | $17.1K | 6.5% |
SUPNSupernus, Inc. | 350.7K | +24.9% | $15.1K | 5.7% |
SNYSanofi | 333.9K | +3.1% | $13.8K | 5.2% |
EMBCEmbecta Corp. | 1.1M | ±0% | $6.4K | 2.4% |
ARDXArdelyx, Inc. | 1.8M | +239.6% | $6.2K | 2.3% |
BNTXBioNTech SE | 59.5K | ±0% | $5.9K | 2.2% |
VNDAVanda Pharmaceuticals Inc. | 1.2M | ±0% | $5.8K | 2.2% |
GSKGSK PLC | 96.7K | ±0% | $4.7K | 1.8% |
BIIBBiogen Inc. | 20K | ±0% | $4.5K | 1.7% |
INMDInMode Ltd. | 120.9K | ±0% | $1.7K | 0.6% |
ANIPANI Pharmaceuticals Inc | 13K | New | $944 | 0.4% |
ACADAcadia Pharmaceuticals Inc | 40K | New | $806 | 0.3% |
ZTSZoetis Inc. | 10K | New | $698 | 0.3% |
EOLSEvolus, Inc. | 58K | −63.3% | $464 | 0.2% |